carfilzomib
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
13 FDA-registered drug labelers
Apicore pharmaceuticals private limited
Chunghwa Chemical Synthesis & Biotech. Ltd
Dr.Reddys Laboratories Limited
HAS Healthcare Advanced Synthesis SA
HETERO LABS LIMITED
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
LAURUS LABS LIMITED
Lianyungang Runzhong Pharmaceutical Co., Ltd.
MSN Laboratories Private Limited
Onyx Pharmaceuticals, Inc.
Patheon Manufacturing Services LLC
Sionc Pharmaceutical Private Limited
TAPI Croatia Industries Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Kyprolis
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS868540-17-4
PubChem CID11556711
DTXSIDDTXSID4048690
FormulaC40H57N5O7
Mol. Weight719.9 g/mol
SMILESCC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4
Data Sources
115567112026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/carfilzomib/cids/JSON
Archive: data/sources/pubchem_name/carfilzomib.json
CAS 868540-17-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json